Were physicians/patients aware of the change in the formulation? [BE/BA News]

posted by nobody – 2017-11-26 19:00 (1946 d 23:52 ago) – Posting: # 18011
Views: 7,403

❝ I think that neither physicians nor patients were aware of what was going on – that wasn’t a product-switch but a change in the formulation. Both thought to take still the same product of the same manufacturer.

Reformulation -> new product. End of story ;-) Endocrinologists don't support any switching. This was a switch without prior info to patients/docs. Failed. Expectable. For this compound. This has never been discussed broadly by the authorities (read stories of proposed scientific meeting on this topic, which never took place). Too much politics. As Mr. Denmark pointed out. :-)

Kindest regards, nobody

Complete thread:

UA Flag
 Admin contact
22,552 posts in 4,724 threads, 1,606 registered users;
14 visitors (0 registered, 14 guests [including 3 identified bots]).
Forum time: 19:52 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz